Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × Erlotinib Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 2 Lung Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

Gemcitabine 26 pembrolizumab 19 Cisplatin 19 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 durvalumab 10 Nivolumab 9 enfortumab vedotin 8 avelumab 8 atezolizumab 7 Carboplatin 7 Mitomycin 6 Docetaxel 6 Cystoscopy 6 Cystectomy 6 Radiation 5 Paclitaxel 5 Biopsy 5 sacituzumab govitecan 4 Transurethral Resection of Bladder 4 Standard of Care 4 Radiotherapy 4 Ipilimumab 4 Fluorouracil 4 erdafitinib 3 dehydroftorafur 3 cabozantinib 3 Practice Guidelines as Topic 3 Platinum 3 Mitozytrex 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡